Pure Global AI
NCT06393920Not yet recruiting

PusledSelect PFA Registry

Medtronic Cardiac Rhythm and Heart FailureClinicalTrials.gov
Verified
Study focus
Disease/Condition
Atrial Fibrillation
Study type
Observational
Sponsor & location
Primary sponsor
Medtronic Cardiac Rhythm and Heart Failure
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2024
End date
Oct 01, 2029
Enrollment
400 participants
Primary outcome

Freedom from Atrial Fibrillation

Summary

PulsedSelect is a prospective, global, multi-center, observational post-approval study.
 Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.

ICD-10 classifications
Chronic atrial fibrillationPersistent atrial fibrillationParoxysmal atrial fibrillationAtrial fibrillation and flutterAtrial fibrillation and atrial flutter, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06393920
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06393920 through Pure Global AI's free database. This phase not specified trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure and is currently Not yet recruiting. The study focuses on Atrial Fibrillation. Target enrollment is 400 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.